Amidst the exit of multinational pharmaceutical companies from Nigeria, the National Agency for Food and Drug Administration and Control (NAFDAC) said a total of 105 applications for the construction and erection of drug manufacturing facilities have been approved across the country.
The regulatory agency said the approved applications, which were selected from a total of 143, meet the Good Manufacturing Practice (GMP) guidelines of the World Health Organisation (WHO) and NAFDAC GMP for Medicinal Products Regulations 2021.
According to a document obtained by PREMIUM TIMES and signed by the Director General of NAFDAC, Mojisola Adeyeye, 35 per cent of the approved applications have completed construction and are at different stages in the registration stream as prescribed by extant NAFDAC’s guidelines on the establishment of pharmaceutical plants in Nigeria.
